Prolor Biotech (PBTH), will be acquired by OPKO Health (OPK) in an all-stock deal worth $480M....

Prolor Biotech (PBTH), will be acquired by OPKO Health (OPK) in an all-stock deal worth $480M. PBTH shareholders will get 0.9551 shares of OPK for every share of PBTH they own, equating to $7 per share as of Tuesday's closing prices. PBTH +10.65% premarket. (Previously: strategic alternative evaluation boosts Prolor)

Comments (3)
  • phedrus4quality
    , contributor
    Comments (30) | Send Message
    Somehwat disappointing....hoping for a white knight
    24 Apr 2013, 09:54 AM Reply Like
  • stockmarketchamp
    , contributor
    Comments (49) | Send Message
    Again great news.....another company with phase 3 candidates..Those of you who are patient will profit BIG....This stock will be in the 20's easily by 2014-2015......Dr.Frost continues to use his connections as ceo of today 6.80 to 7.00 ....buying opportunity.Patience is the key.......Very soon this stock is going to open in the morning very high and you will be MAD you sold the day before....remember what I know ...not what I said.
    24 Apr 2013, 12:26 PM Reply Like
  • Kirk85
    , contributor
    Comments (10) | Send Message
    anyone know when this closes??
    13 Jul 2013, 10:16 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs